11 September 2014 in Current Alzheimer Research
With a longer life expectancy and an increased prevalence of neurodegenerative diseases, investigations on trajectories of cognitive aging have become exciting and promising. This study aimed to estimate the patterns of age-related cognitive decline and the potential associated factors of cognitive function in community-dwelling residents of Beijing, China. In this study, 1248 older adults aged 52-88 years [including 175 mild cognitive impairment (MCI) subjects] completed a battery of neuropsychological scales. The personal information, including demographic information, medical history, eating habits, lifestyle regularity and leisure activities, was also collected. All cognitive function exhibited an agerelated decline in normal volunteers. Piece-wise linear fitting results suggested that performance on the Auditory Verbal Learning Test remained stable until 58 years of age and continued to decline thereafter. The decline in processing speed and executive function began during the early 50’s. Scores on visual-spatial and language tests declined after 66 years of age. The decline stage of the general mental status ranged from 63 to 70 years of age. However, the MCI group did not exhibit an obvious age-related decline in most cognitive tests. Multivariate linear regression analyses indicated that education, gender, leisure activities, diabetes and eating habits were associated with cognitive abilities. These results indicated various trajectories of age-related decline across multiple cognitive domains. We also found different patterns of agerelated cognitive decline between MCI and normal elderly. These findings could help improve the guidance of cognitive intervention program and have implications for public policy issues.
1 January 2024 in Women's Health
Background: Lymph node metastasis is associated with a poorer prognosis in endometrial cancer. Objective: The objective was to synthesize and critically appraise existing predictive models for lymph node metastasis risk stratification in endometrial cancer. Design: This study is a systematic review. Data Sources and Methods: We searched the Web of Science for articles reporting models predicting lymph node metastasis in endometrial cancer, with a systematic review and bibliometric analysis conducted based upon which. Risk of bias was assessed by the Prediction model Risk Of BiAS assessment Tool (PROBAST). Results: A total of 64 articles were included in the systematic review, published between 2010 and 2023. The most common articles were “development only.” Traditional clinicopathological parameters remained the mainstream in models, for example, serum tumor marker, myometrial invasion and tumor grade. Also, models based upon gene-signatures, radiomics and digital histopathological images exhibited an acceptable self-reported performance. The most frequently validated models were the Mayo criteria, which reached a negative predictive value of 97.1%–98.2%. Substantial variability and inconsistency were observed through PROBAST, indicating significant between-study heterogeneity. A further bibliometric analysis revealed a relatively weak link between authors and organizations on models predicting lymph node metastasis in endometrial cancer. Conclusion: A number of predictive models for lymph node metastasis in endometrial cancer have been developed. Although some exhibited promising performance as they demonstrated adequate to good discrimination, few models can currently be recommended for clinical practice due to lack of independent validation, high risk of bias and low consistency in measured predictors. Collaborations between authors, organizations and countries were weak. Model updating, external validation and collaborative research are urgently needed. Registration: None.
4 May 2025 in Gynecology and Obstetrics Clinical Medicine
EAExpert Committee of Obstetrics and Gynecology of the Chinese Research Hospital Association
Expert Committee of Obstetrics and Gynecology of the Chinese Research Hospital Association
+2
Endometrial cancer (EC) is one of the most common gynaecologic malignancies, with a rising incidence in China. In 2022, an estimated 84 520 new cases were diagnosed, and 17 543 deaths were reported in China.1 The traditional Bokhman classification, proposed in 1983, categorised EC into type I (oestrogen-dependent) and type II (non-oestrogen-dependent) based on clinicopathological features.2 However, with rapid advances in oncology, the diagnosis and treatment of EC have evolved beyond conventional clinicopathological classifications. Integrating molecular features into precision medicine has emerged as a key challenge in the field. While the Cancer Genome Atlas (TCGA) molecular classification of EC3 was introduced over a decade ago and has garnered increasing attention from Chinese experts and scholars,4 5 its clinical implementation remains in the exploratory phase. In response to this situation, a panel of Chinese gynaecologic oncologists and pathologists has developed this consensus statement, based on current literature and clinical experience, to guide the application of molecular classification in clinical practice.
1 January 2025 in Journal of Gynecologic Oncology
Zhai Z, et al. J Gynecol Oncol. 2025 Apr;36:e101. https://doi.org/10.3802/jgo.2025.36.e101
5 April 2022 in Journal of Obstetrics and Gynaecology Research
1 December 2025 in Translational Cancer Research
Background: Laparoscopy for early/low-risk endometrial cancer (EC) is safe, but evidence for high-risk cases is insufficient. This study aimed to compare perioperative safety and survival outcomes between high-risk EC patients receiving laparoscopic surgery and laparotomy. Methods: A total of 267 high-risk EC patients (stage IA, grade 3; stage IA, type II tumors; stage IB-III, regardless of histologic grade) undergone surgery in Peking University People’s Hospital from 2006 to 2016 were retrospectively enrolled in the study. To evaluate the safety of laparoscopic surgery, the incidence of perioperative complications and long-term oncological outcomes were compared between patients receiving laparoscopic surgery or laparotomy. Survival analysis was performed using the Kaplan-Meier method and Cox regression. Results: Laparoscopic approach was associated with shorter mean operative time (183.0±60.3 vs. 202.3±67.0 mins, P=0.02), less blood loss (210.2±255.5 vs. 484.9±328.2 mL, P<0.001) and lower transfusion rate (10.4% vs. 31.6%, P<0.001) than laparotomy. Both Kaplan-Meier method and univariate Cox regressions showed that laparoscopic surgery and laparotomy had similar 5-year disease-free (88.8% vs. 84.6%, P=0.33) and overall survival (95.6% vs. 90.2%, P=0.58). In multivariate analysis, both stage and grade were associated with oncological outcomes whereas surgical approach was not a risk factor for prognosis. Conclusions: Laparoscopic surgery is effective and safe in high-risk EC, though further validations by randomized clinical trials are needed.